BLSM
BlossomHill Therapeutics, Inc.
21.30$
+8.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
BlossomHill Therapeutics, Inc. (BLSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -47 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -31 | -47 | |
| 0.4 | 0.4 | |
| 0.5 | 1.1 | |
| -2.3 | 11 | |
| 0.1 | 1.1 | |
| -0.1 | -1.1 | |
| 18 | 85 | |
| -14 | 37 | |
| -32 | -48 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.